1H-3-BENZAZEPIN-7-OL, 5-(7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)-
Colon Cancer
National Cancer Institute (NCI)Small moleculePhase 1/2Dormant
CC
41/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 65/ 100
Competitive context
128 Active assets in the Colon Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FLUOROURACILUM Akeso | Phase 4 | BB |
Eloxatin Sun Yat-sen University | Phase 3 | BB |
Calcium folinate pentahydrate Akeso | Phase 3 | BB |
Irinotecan SCRI Development Innovations, LLC | Phase 3 | BB |
MACROGOLS University Medical Center Ho Chi Minh City (UMC) | Phase 4 | BB |
View all 50 →
Same molecule, other indications
1H-3-BENZAZEPIN-7-OL, 5-(7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)- is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →